Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Boyd

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Military Medicine|January 14, 2005
Unilateral lower extremity edema in May-Thurner syndromeDavid A Boyd
The Journal of Antimicrobial Chemotherapy|June 1, 2006
OXA-1 is OXA-30 is OXA-1David A Boyd, Michael R Mulvey
Antimicrobial Agents and Chemotherapy|August 19, 2009
TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolateMichael R Mulvey, David A Boyd
Journal of Strength and Conditioning Research|June 12, 2014
Comparison of acute countermovement jump responses after functional isometric and dynamic half squatsDavid A Boyd, Neil Donald, Thomas G Balshaw
Antimicrobial Agents and Chemotherapy|February 24, 2006
Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) geneDavid A Boyd, Mark A Miller, Michael R Mulvey
The Journal of Family Practice|January 7, 2011
Teen with a diffuse erythematous, pruritic eruptionChristopher R Worley, Larissa S Buccolo, David A Boyd
Emerging Infectious Diseases|July 24, 2009
Eczema herpeticum and clinical criteria for investigating smallpoxDavid A Boyd, Leonard C Sperling, Scott A Norton
The Journal of Antimicrobial Chemotherapy|August 17, 2004
Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operonDavid A Boyd, Pamela Kibsey, Diane Roscoe, et al.
Nano Letters|November 14, 2009
Heterogenous catalysis mediated by plasmon heatingJames R Adleman, David A Boyd, David G Goodwin, et al.
Analytical Chemistry|March 7, 2008
Chemical separations by bubble-assisted interphase mass-transferDavid A Boyd, James R Adleman, David G Goodwin, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Military Medicine|January 14, 2005
Unilateral lower extremity edema in May-Thurner syndromeDavid A Boyd
The Journal of Antimicrobial Chemotherapy|June 1, 2006
OXA-1 is OXA-30 is OXA-1David A Boyd, Michael R Mulvey
Antimicrobial Agents and Chemotherapy|August 19, 2009
TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolateMichael R Mulvey, David A Boyd
Journal of Strength and Conditioning Research|June 12, 2014
Comparison of acute countermovement jump responses after functional isometric and dynamic half squatsDavid A Boyd, Neil Donald, Thomas G Balshaw
Antimicrobial Agents and Chemotherapy|February 24, 2006
Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) geneDavid A Boyd, Mark A Miller, Michael R Mulvey
The Journal of Family Practice|January 7, 2011
Teen with a diffuse erythematous, pruritic eruptionChristopher R Worley, Larissa S Buccolo, David A Boyd
Emerging Infectious Diseases|July 24, 2009
Eczema herpeticum and clinical criteria for investigating smallpoxDavid A Boyd, Leonard C Sperling, Scott A Norton
The Journal of Antimicrobial Chemotherapy|August 17, 2004
Enterococcus faecium N03-0072 carries a new VanD-type vancomycin resistance determinant: characterization of the VanD5 operonDavid A Boyd, Pamela Kibsey, Diane Roscoe, et al.
Nano Letters|November 14, 2009
Heterogenous catalysis mediated by plasmon heatingJames R Adleman, David A Boyd, David G Goodwin, et al.
Analytical Chemistry|March 7, 2008
Chemical separations by bubble-assisted interphase mass-transferDavid A Boyd, James R Adleman, David G Goodwin, et al.
Pageof 7